Jennifer Shirey PA-C

Recommended Articles

• Carol Burnett's Beloved Sidekick, Tim Conway, Is Battling Dementia

  A person's age or status does not matter when dementia is in the picture. Dementia is a blanket term for deterioration in mental and cognitive ability. Over time, dementia can progress enough to interfere with someone's daily life. ...

• Unique Social Clubs for Women On the Spectrum

  For people with autism, social activities can be both difficult and stressful. This can often lead to avoidance of such situations, which in turn leads to isolation. As humans are social beings, lack of interaction with other people can leave many feeling depressed.For one young woman with autism,...

• Understanding Social Anxiety Disorder in Parkinson's Disease

  It is natural to have some kind of emotional distress, anxiety, and sadness when diagnosed with Parkinson’s disease. But SAD is not just about being sad, it is being anxious and fearful of participating in social activities. SAD is an abbreviation for social anxiety disorder also known as social...

• Nuts and your heart: Eating nuts for heart health

  Whether roasted or raw, walnuts are the best nuts and have an abundance of heart healthy nutrients. In a recent study, researchers compared the amount of polyphenols — the powerful antioxidants — in nine types of roasted and raw nuts. They also measured the amount of these antioxidants in two...

• Is Syphilis Curable?

  Syphilis is a venereal disease caused by the bacterium Treponema pallidum. It is sexually transmitted and takes second place among the most dangerous STDs after HIV. It has four stages, among which primary and secondary are the most infectious. It is also transmitted from an infected pregnant...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...